การวิจัยและพัฒนาโปรแกรมคอมพิวเตอร์เพื่อป้องกันการสั่งใช้ยาซ้ำซ้อนในโรงพยาบาลมหาสารคาม

Chutimaporn Chaiyasong; Piriya Tiyapak; Kanjanaporn Taratai; Sathaporn Na Rajsima; Surasak Chaiyasong

Authors

Chutimaporn Chaiyasong Department of Pharmacy, Mahasarakham Hospital
Piriya Tiyapak Department of Pharmacy, Mahasarakham Hospital
Kanjanaporn Taratai Department of Health Information Technology, Mahasarakham Hospital
Sathaporn Na Rajsima Department of Pediatrics, Mahasarakham Hospital
Surasak Chaiyasong Social Pharmacy Research Unit, Faculty of Pharmacy, Mahasarakham University

Keywords:

duplicate drug prescription, rational drug use, computerized program

Abstract

Background & Rationale: Duplicate medication is irrational drug use that can cause adverse drug events to patients and wasteful health expenditure. There have been a limited number of studies on duplicate prescribing in Thailand. The objective of this study was to develop a computer software to prevent therapeutic duplicate prescription and to determine its effects in Mahasarakham Hospital. Methodology: This research and development comprised three parts. Part 1 described characteristics and magnitudes of duplicate drug prescribing in the hospital using electronic database of 12 drug groups (39 drug items) during 1 October 2018 – 30 September 2019. Part 2 developed a computer software based on results of part 1 and implemented the software in November 2019. Part 3 examined effects of the software by comparing proportions of duplicate drug prescriptions during, before (November 2017 – April 2018) and after software implementation (November 2019 – April 2020). Results: Of total 218,179 prescriptions, 818 duplicates (0.37%) were found, of which 576 (0.26%) were duplicate medication at the same therapeutic groups and 242 (0.11%) at the same drug item. Moreover, 530 duplicates (0.24%) were detected in the same prescription and 288 duplicates (0.13%) detected in the same patient. The highest duplicate medication rate was found in the gastric secretion inhibitors group (378/36,495 prescriptions, 1.04%), followed by antihistamine (130/13,433 prescriptions, 0.97%) and NSAIDs (184/29,783 prescriptions, 0.62%). These duplicates costed around 19,740 – 79,591 baht/year. The software detected any duplicate medications prescribed in the same therapeutic drug, same patient and same day and alert prescribers/pharmacists for clarification. After software implementation, the duplicate drug prescribing decreased significantly from 0.27% (266/100,367 prescriptions) to 0.08% (75/95,350 prescriptions) or a 70.3% reduction (OR 0.296, 95%CI: 0.226-0.384, p < 0.001). The excess healthcare cost declined by 4,098 – 18,360 baht/6 months or 8,196 – 36,720 baht/year. Conclusion: The developed computer software was effective in preventing duplicate prescription and reducing unnecessary healthcare cost. Future studies should determine duplicate drug prescription and prevention program at national level to support rational drug use and reduce healthcare cost in Thailand.

References

Kim DS, Je NK, Kim GJ, Kang H, Kim YJ, Lee S. Therapeutic duplicate prescribing in Korean ambulatory care settings using the National Health Insurance claim data. Int J Clin Pharm. 2015 Feb;37(1):76-85.

Lee H, Song I, Shin SM, Jeong HE, Lee EK, Shin JY. Regulatory effect of decreasing therapeutic duplication of respiratory drugs using a prescription database between 2012 and 2015. Regul Toxicol Pharmacol. 2019 Apr;103:218-28.

Kinoshita H, Kobayashi Y, Fukuda T. Duplicative medications in patients who visit multiple medical institutions among the insured of a corporate health insurance society in Japan. Health Policy. 2008 Jan;85(1):114-23.

Kang HA, Lee SM, Park C, Kim DS. Prevalence and predictors of non-steroidal anti-inflammatory drug/analgesic therapeutic duplication in the South Korean ambulatory care setting. Eur J Clin Pharmacol. 2016 Jan;72(1):109-16.

Heinze G, Jandeck LM, Hronsky M, Reichardt B, Baumgärtel C, Bucsics A, et al. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study. Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):90-9.

Azoulay L, Zargarzadeh A, Salahshouri Z, Oraichi D, Berard A. Inappropriate medication prescribing in community-dwelling elderly people living in Iran. Eur J Clin Pharmacol. 2015;61:913–9.

Chanatepaporn P. Development of prescribing error program for reporting in Srinagarind Hospital. Srinagarind Medical Journal. 2019;34(3):261-70. (in Thai)

Benjanakaskul P. The incidence of duplicate medication prescription in outpatient pharmacy setting at Siriraj Hospital. Siriraj Medical Bulletin. 2559;9(2):53-61. (in Thai)

Evans KD, Benham SW, Garrard CS. A comparison of handwritten and computer-assisted prescriptions in an intensive care unit. Crit Care 1998;2(2):73–8.

Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, et al. Role of computerized physician order entry systems in facilitating medication errors. JAMA 2005;293:1197–203.

Colpaert K, Claus B, Somers A, Vandewoude K, Robays H, Decruyenaere J. Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial. Crit Care 2006;10(1):R21. Doi: 10.1186/cc3983.

Kuperman GJ, Bobb A, Payne TH, Avery AJ, Gandhi TK, Burns G, et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc. 2007;14(1):29–40.

Magid S, Forrer C, Shaha S. Duplicate orders: an unintended consequence of computerized provider/physician order entry (CPOE) implementation: analysis and mitigation strategies. Appl Clin Inform. 2012;3(4):377-91.

WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2019. Oslo, 2018. ISBN 978-82-8082-974-0. [cited 2019 October 31]. Available from: https://www.whocc.no/filearchive/publications/2019_guidelines_web.pdf.

Thai Motility Club, The Gastroenterological Association of Thailand. 2004 consensus for clinical practice guideline for the management of gastroesophageal reflux disease. Bangkok: Union Creation; 2004. (in Thai)